132
Views
0
CrossRef citations to date
0
Altmetric
Research Aricles

Post-recurrence survival analysis of patients with pulmonary recurrence from gynaecologic cancers: a multi-institutional analysis of 122 patients

ORCID Icon, ORCID Icon, ORCID Icon, ORCID Icon, ORCID Icon, ORCID Icon, ORCID Icon, ORCID Icon, ORCID Icon, ORCID Icon, ORCID Icon, ORCID Icon, ORCID Icon, ORCID Icon, ORCID Icon, ORCID Icon, ORCID Icon, ORCID Icon, ORCID Icon, ORCID Icon, ORCID Icon, ORCID Icon, ORCID Icon, ORCID Icon & ORCID Icon show all

References

  • Adachi M, Mizuno M, Mitsui H, Kajiyama H, Suzuki S, Sekiya R, et al. 2015. The prognostic impact of pulmonary metastasectomy in recurrent gynecologic cancers: a retrospective single-institution study. Nagoya Journal of Medical Science 77:363–372.
  • Anraku M, Yokoi K, Nakagawa K, Fujisawa T, Nakajima J, Akiyama H, et al. 2004. Pulmonary metastases from uterine malignancies: results of surgical resection in 133 patients. Journal of Thoracic and Cardiovascular Surgery 127:1107–1112.
  • Ansell SM, Rapoport BL, Falkson G, Raats JI, Moeken CM. 1993. Survival determinants in patients with advanced ovarian cancer. Gynecologic Oncology 50:215–220.
  • Berman AT, Thukral AD, Hwang W-T, Solin LJ, Vapiwala N. 2013. Incidence and patterns of distant metastases for patients with early-stage breast cancer after breast conservation treatment. Clinical Breast Cancer 13:88–94.
  • Bouros D, Papadakis K, Siafakas N, Fuller AF. 1996. Natural history of patients with pulmonary metastases from uterine cancer. Cancer 78:441–447.
  • Bruzzone M, Miglietta L, Franzone P, Gadducci A, Boccardo F. 2004. Combined treatment with chemotherapy and radiotherapy in high-risk FIGO stage III–IV endometrial cancer patients. Gynecologic Oncology 93:345–352.
  • Chambers AF, Groom AC, MacDonald IC. 2002. Dissemination and growth of cancer cells in metastatic sites. Nature Reviews. Cancer 2:563–572.
  • Clavero JM, Deschamps C, Cassivi SD, Allen MS, Nichols FC, Barrette BA, et al. 2006. Gynecologic cancers: factors affecting survival after pulmonary metastasectomy. Annals of Thoracic Surgery 81:2004–2007.
  • Dowdy SC, Mariani A, Bakkum JN, Cliby WA, Keeney GL, Podratz KC. 2007. Treatment of pulmonary recurrences in patients with endometrial cancer. Gynecologic Oncology 107:242–247.
  • Dresler CM, Goldberg M. 1996. Surgical management of lung metastases: selection factors and results. Oncology 10:649–655.
  • Fagotti A, Ferrandina MG, Vizzielli G, Pasciuto T, Fanfani F, Gallotta V, et al. 2020. Randomized trial of primary debulking surgery versus neoadjuvant chemotherapy for advanced epithelial ovarian cancer (SCORPION-NCT01461850). International Journal of Gynecologic Cancer 30:1657–1664.
  • Gülseren V, Kocaer M, Güngördük Ö, Özdemir İA, Gölbaşı C, Budak A, et al. 2018. Isolated pulmonary metastases in patients with cervical cancer and the factors affecting survival after recurrence. Ginekologia Polska 89:593–598.
  • Hacker NF, Rao A. 2016. Surgical management of lung, liver and brain metastases from gynecological cancers: a literature review. Gynecologic Oncology Research and Practice 3:1–13.
  • Hirosawa T, Itabashi M, Ohnuki T, Yamaguchi N, Sugihara K, Kameoka S; Japanese Society for Cancer of the Colon and Rectum (JSCCR) Study Group for Pulmonary Metastases from Colorectal Cancer. 2013. Prognostic factors in patients undergoing complete resection of pulmonary metastases of colorectal cancer: a multi-institutional cumulative follow-up study. Surgery Today 43:494–499.
  • Humber CE, Tierney JF, Symonds RP, Collingwood M, Kirwan J, Williams C, et al. 2007. Chemotherapy for advanced, recurrent or metastatic endometrial cancer: a systematic review of Cochrane collaboration. Annals of Oncology 18:409–420.
  • Jemal A, Bray F, Forman D, O’Brien M, Ferlay J, Center M, et al. 2012. Cancer burden in Africa and opportunities for prevention. Cancer 118:4372–4384.
  • Laganà AS, Colonese F, Colonese E, Sofo V, Salmeri FM, Granese R, et al. 2015. Cytogenetic analysis of epithelial ovarian cancer’s stem cells: an overview on new diagnostic and therapeutic perspectives. European Journal of Gynaecological Oncology 36:495–505.
  • Li H, Wu X, Cheng X. 2016. Advances in diagnosis and treatment of metastatic cervical cancer. Journal of Gynecologic Oncology 27:e43.
  • Panek G, Gawrychowski K, Sobiczewski P, Derlatka P, Danska-Bidzinska A, Gmyrek L, et al. 2007. Results of chemotherapy for pulmonary metastases of carcinoma of the cervix in patients after primary surgical and radiotherapeutic management. International Journal of Gynecological Cancer 17:1056–1061.
  • Thigpen T. 2003. The role of chemotherapy in the management of carcinoma of the cervix. Cancer Journal 9:425–432.
  • Turan T, Ureyen I, Karalok A, Tasci T, Turkmen O, Kocak O, et al. 2016. Pulmonary recurrence in patients with endometrial cancer. Journal of the Chinese Medical Association 79:212–220.
  • Ueda Y, Matsumura Y, Egawa-Takata T, Miyake T, Miyatake T, Yoshino K, et al. 2010. Disease-free interval after primary treatment predicts prognosis of recurrent endometrial carcinoma. Anticancer Research 30:4347–4352.
  • Vermorken J. 1993. The role of chemotherapy in squamous cell carcinoma of the uterine cervix: a review. International Journal of Gynecological Cancer 3:129–142.
  • World Health Organization. 1979. WHO handbook for reporting results of cancer treatment. Geneva: World Health Organization.
  • Yamamoto K, Yoshikawa H, Shiromizu K, Saito T, Kuzuya K, Tsunematsu R, et al. 2004. Pulmonary metastasectomy for uterine cervical cancer: a multivariate analysis. Annals of Thoracic Surgery 77:1179–1182.
  • Yano T, Shoji F, Maehara Y. 2009. Current status of pulmonary metastasectomy from primary epithelial tumors. Surgery Today 39:91–97.
  • Yoshida K, Kajiyama H, Utsumi F, Niimi K, Sakata J, Suzuki S, et al. 2017. A post-recurrence survival‑predicting indicator for cervical cancer from the analysis of 165 patients who developed recurrence. Molecular and Clinical Oncology 8:281–285.
  • Zink S, Kayser G, Gabius H-J, Kayser K. 2001. Survival, disease-free interval, and associated tumor features in patients with colon/rectal carcinomas and their resected intra-pulmonary metastases. European Journal of Cardio-Thoracic Surgery 19:908–913.

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.